Smart Inhalers Market By Product Type (Dry Powder Inhalers and Metered Dose Inhalers), Disease Indication (Chronic Obstructive Pulmonary Disease (COPD) and Asthma), Distribution channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) -Analysis & Forecast 2020-2030.
Report ID : 324 | Published Date : Jul 2020 | Pages : 160 | Region : Global | Report Code : MD-100
Smart Inhalers Market Overview and Introduction
The first-line treatment for diseases, such as cystic fibrosis, asthma, chronic bronchitis, and sinusitis, amongothers, is the inhalation of the medication. The effectiveness of inhalation is related to the amount of drug deposited beyond the oropharyngeal region. It is also important to consider the size of the inhaled particles, the breathing conditions, the geometry of airways, and the mucociliary clearance mechanisms.Smart inhalers come with extra digital features; they are linked to an app on a phone or a tablet to help patients and doctorsto manage respiratory diseases better. Smart inhalers are designed to automatically track how often patients are using an inhaler and helping doctors to track disease progression in patients.
The global smart inhalers marketis mainly driven bygrowing incidentsof respiratory diseases globally. According to the WHO, more than 65 million people suffer from Chronic Obstructive Pulmonary Diseases (COPD) each year and more than 3 million people die from it.Moreover, theincreasing demand for home healthcare devices and the rising geriatric populationalso play a pivotal role in contributing to market growth globally. However,the lack of awareness among the patients regarding novel technologiesand thelimited availability of the product in emerging regionsislikely to restrainmarketgrowthto a certain extent.
The global smart inhalers marketcan besegmented intoproduct type, disease indication,distribution channel, and regions.
Smart Inhalers Market By Product Type
Based on product type, the market can besegmented into dry powder inhalers and metered dose inhalers.The dry powder inhalers segmentis expected to dominate the smart inhalers market during the forecast period.The segment growth can be attributed tothe huge number of research studies and product developments in dry powder inhalers across the globe.
Smart Inhalers Market By Disease Indication
Based on disease indication, the market can besegmented into Chronic Obstructive Pulmonary Disease (COPD), asthma, and others. The COPDsegment is expected togrow at the highest CAGRduring the forecast period owing to its increasing incidents and rising awareness regarding smart inhalers among COPD patients.
Smart Inhalers Market By Distribution Channel
Based onthe distribution channel, the market can be segmented intohospital pharmacies, retail pharmacies, and online pharmacies.The hospital pharmaciessegmentis expected to dominate the smart inhalers marketduring the forecastperiod.Hospital pharmacies are well connected and easily accessible to patients taking treatments from the hospital, facilitating growth of the segment.
Smart Inhalers Market By Region
Based onthe region,the global smart inhalers marketcan be segmented into North America, Europe, Asia Pacific, and the Rest of the World (ROW). North America dominated the smart inhalers market followed by Europe. The large share of North Americacan be attributed totechnological advancements and affordability of smart inhalers among the target population in the region.
Smart Inhalers Market Prominent Players
Some of the prominent players in the smart inhalers market include AstraZeneca plc, GlaxoSmithKline plc, Novartis AG, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., AptarGroup, Inc., Vectura Group plc, Findair Sp. z o. o., H&T Presspart Manufacturing Ltd., and Zeolr Technologies Pvt Ltd,among others.